Location History:
- Itano-gun, JP (2014)
- Tokushima, JP (2011 - 2018)
Company Filing History:
11 out of 846 
1 out of 2 Years Active: 2011-2018
Title: **Inventor Spotlight: Tomonori Nakagawa**
Introduction
Tomonori Nakagawa is a prominent inventor located in Tokushima, Japan. He holds an impressive portfolio of 12 patents, showcasing his innovative contributions primarily in the pharmaceutical field. Nakagawa's work focuses on improving the stability and performance of pharmaceutical compounds, particularly aripiprazole, which is notable for its application in treating mental health disorders.
Latest Patents
Among his latest patents is the invention titled "Low Hygroscopic Aripiprazole Drug Substance and Processes for the Preparation Thereof." This innovation presents low hygroscopic forms of aripiprazole and processes for their preparation, ensuring that these forms do not convert to a hydrate or lose their solubility over time, even when stored in medicinal preparations. This advancement enhances the reliability and efficacy of aripiprazole in clinical applications, reflecting Nakagawa's commitment to improving patient outcomes through innovative drug formulations.
Career Highlights
Throughout his career, Tomonori Nakagawa has made significant strides in pharmaceutical research and development. He has been associated with Otsuka Pharmaceutical Company, Limited and Otsuka Pharmaceutical Co. Ltd., where he has dedicated his expertise towards creating impactful medicinal products. His patents not only contribute to the advancement of drug formulations but also underline his reputation as a leading inventor in the industry.
Collaborations
Tomonori Nakagawa has collaborated with notable colleagues such as Takuji Bando and Satoshi Aoki. These partnerships have allowed him to enhance his research and expand the possibilities of his innovative projects, further propelling his contributions in the field of pharmaceuticals.
Conclusion
In summary, Tomonori Nakagawa's innovative work, particularly in the development of low hygroscopic forms of aripiprazole, demonstrates his significant role as an inventor in the pharmaceutical industry. With a robust collection of patents and collaborative efforts, Nakagawa continues to impact the field positively, paving the way for future advancements in drug formulation and therapeutic efficacy. His contributions not only represent personal achievement but also promise improved medical solutions for many patients around the globe.